The more I read, the more I buy. The more I buy, the more I want to buy more. I know I can't this much exposure to a biotech in Ph3 trials, but I do. Ended with so many shares that I could be in top 15 institutional investors list (doesn't take much I guess). Would want this to come to a conclusion one way or other.